Cholesterol Drug Fenofibrate Reduces Risk of Amputation in Diabetics

May 22, 2009 by


Boston (HealthKnowItAll) - Diabetes patients given the drug fenofibrate, have been found to be at a reduced risk of needing amputations.

This news comes from a study carried out by researchers from Australia, Finland and New Zealand.

Fenofibrate, was originally intended to be used by people to lower their levels of bad cholesterol, but has been found to also be helpful for diabetics.

Diabetes is a condition in which the pancreas does not function properly, thus it can not produce sufficient levels of the hormone insulin to manage the body’s blood sugar.

In some cases the disease can damage nerves and blood vessels, which can lead to forced amputation of body parts such as fingers and toes.

In a study, researchers compared the effects of fenofibrate to those of a placebo, and saw a marked advantage to prescribing the drug to diabetes patients.

Those taking the drug were found to be 36% less likely to suffer a minor amputation than those patients given a placebo.

The study is published in the Lancet.

Comments are closed.